Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. One out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 29 points (-0.2%) at 16,367 as of Wednesday, March 5, 2014, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,229 issues advancing vs. 1,681 declining with 174 unchanged. The Health Services industry currently sits down 0.1% versus the S&P 500, which is unchanged. Top gainers within the industry include Select Medical Holdings Corporation ( SEM), up 4.3%, Globus Medical ( GMED), up 4.0% and DexCom ( DXCM), up 2.5%. On the negative front, top decliners within the industry include Mindray Medical International Limited ADR r ( MR), down 1.8%, Fresenius Medical Care AG & Co. KGaA ( FMS), down 1.3%, CareFusion ( CFN), down 1.1%, Becton Dickinson ( BDX), down 0.9% and HCA Holdings ( HCA), down 0.9%. TheStreet would like to highlight 3 stocks pushing the industry higher today: 3. Aetna ( AET) is one of the companies pushing the Health Services industry higher today. As of noon trading, Aetna is up $0.48 (0.7%) to $74.13 on light volume. Thus far, 878,014 shares of Aetna exchanged hands as compared to its average daily volume of 2.6 million shares. The stock has ranged in price between $73.11-$74.22 after having opened the day at $73.52 as compared to the previous trading day's close of $73.65. Aetna Inc. operates as a diversified health care benefits company in the United States. The company operates in three segments: Health Care, Group Insurance, and Large Case Pensions. Aetna has a market cap of $26.2 billion and is part of the health care sector. Shares are up 5.3% year-to-date as of the close of trading on Tuesday. Currently there are 12 analysts who rate Aetna a buy, no analysts rate it a sell, and 5 rate it a hold. TheStreet Ratings rates Aetna as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, growth in earnings per share and compelling growth in net income. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Aetna Ratings Report now. 3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.